Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
124.00
+11.00 (9.73%)
Sep 8, 2026, 12:37 PM CST

Handa Pharmaceuticals Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
490.22749.77472.74726.89-40.01-247.67
Depreciation & Amortization
164.25163.8310.1612.1514.8216.49
Other Amortization
0.310.310.270.30.3618.67
Loss (Gain) From Sale of Assets
-12.84-12.840.19-4.610-0.02
Loss (Gain) on Equity Investments
1.34-0.291.81-2.37--
Stock-Based Compensation
21.4116.3922.398.470.110.26
Other Operating Activities
-141.38-21.13-189.2351.87-5.55-13.62
Change in Accounts Receivable
105.56-762.56207.08-226.18-140.5813.41
Change in Inventory
-0.8639.22--10.11-
Change in Accounts Payable
47.9647.046.578.345.1-8.26
Change in Other Net Operating Assets
-13.9623.9-34.3893.51-55.9341.51
Operating Cash Flow
662.01243.63497.6668.36-211.57-179.24
Operating Cash Flow Growth
162.43%-51.04%-25.55%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-28.72-16.92-7.77-0.94-0.64-5.58
Sale of Property, Plant & Equipment
--0-00.03
Cash Acquisitions
3.4-155.9-819.63---
Divestitures
----10.97--
Sale (Purchase) of Intangibles
--0.17---0.12-1.57
Investment in Securities
-380.01-674.86431.12-1,65330.713.98
Other Investing Activities
---0.65--0.450.23
Investing Cash Flow
-405.33-847.84-396.92-1,66529.5-2.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--13.26-6.07-7.17-7.19-7.77
Lease Payments
-13.24-13.26-6.07-7.17-7.19-7.77
Total Debt Repaid
-13.24-13.26-6.07-7.17-7.19-7.77
Net Debt Issued (Repaid)
-13.24-13.26-6.07-7.17-7.19-7.77
Issuance of Common Stock
944.512,1023.121,313320.83170.68
Repurchase of Common Stock
-446.38-57.88-56.52---
Common Dividends Paid
-236.3-236.3-141.09---
Other Financing Activities
-3-3----
Financing Cash Flow
245.591,792-200.551,306313.65162.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.0322.3930.2-8.34-28.972.44
Net Cash Flow
501.241,210-69.67301.13102.6-16.81

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
633.29226.72489.84667.42-212.21-184.82
Free Cash Flow Growth
167.59%-53.72%-26.61%---
Free Cash Flow Margin
52.29%13.11%58.97%60.33%-107.35%-632.19%
Free Cash Flow Per Share
3.901.463.474.95-1.69-1.57
Levered Free Cash Flow
622.45287.3438.42450.86-224.91-74.36
Unlevered Free Cash Flow
623.13287.95438.73450.99-224.74-74.21
Free Cash Flow After Leases
620.05213.46483.77660.25-219.4-192.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.091.040.490.220.280.23
Cash Income Tax Paid
231.79191.19197.467.782.420.45
Change in Working Capital
138.71-652.4179.27-124.33-181.3146.66